Silvio Danese

217PUBLICATIONS
367CO-AUTHORS
Major global burdens of diseaseToxicology (incl. clinical toxicology)Infant and child healthCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (217)

|Jul 28, 2026
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.

|Jul 21, 2026
Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial.

|Jul 16, 2026
Comparative performance of intestinal ultrasound activity indices in pediatric ulcerative colitis: a prospective study.

|Jul 15, 2026
Machine Learning for Colitis-Associated Cancer in Inflammatory Bowel Disease: Evidence and Future Directions Toward Precision Medicine, a Narrative Review.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 19, 2026
Precision nutrition for the prevention and management of inflammatory bowel disease.

Pageof 37

Frequent Collaborators

51 joint publications

Laurent Peyrin-Biroulet

16 joint publications

Ferdinando D'Amico

16 joint publications

Séverine Vermeire

15 joint publications

Fernando Magro